Page 972 - Cardiac Nursing

AM
P
a
1-9
10
:37
g
8 A
pta
ra
e
p94
94
58.
LWB
LWBK340-ind_p941-958.qxd 7/1/09 10:37 AM Page 948 Aptara
K34
nd_
0-i
09
7
qxd
/
/
1
948 Index
%XERCISE TESTING CONTINUED &LUID S IN HUMANS
SAFETY AND PERSONNEL n COMPARTMENTS OF CANDIDATE GENES IMPLICATED IN RISK FOR T
SELECTION EXERCISE TEST n EXCRETION T RHEUMATIC
IN SPECIAL POPULATION INTAKE FOR STROKE
ELDERLY LOSS BY ABNORMAL ROUTES FUNCTIONAL AND THERAPEUTIC CLASSIFICATION T
PATIENT AFTER CARDIAC TRANSPLANTATION &LUID RESUSCITATION D VALVULAR DIAGNOSIS OF
WOMEN n &OAM CELLS (EART FAILURE
FOR STOPPING D &ONDAPARINUX ACUTE
SUBMAXIMAL TESTING FOR ANTICOAGULATION T HEMODYNAMICALLY DIRECTED PROTOCOL FOR D
TERMINATION n FACTOR 8A INHIBITOR INITIAL MANAGEMENT OF D
TERMS USED TO DEMONSTRATE D IN PROPHYLAXIS APPROACH TO TREATMENT n
D
D
%XERCISE TRAINING D 3EE ALSO %XERCISE &RACTIONAL &LOW 2ESERVE &&2 CHRONIC T
CHANGE IN RISK FACTORS D &RANK 3TARLING MECHANISM COMPARISON OF ACUTE VS CHRONIC T
CONTRAINDICATIONS TO n &REE FATTY ACIDS &&! CONDITIONS ASSOCIATED WITH T
%XERTION SCALE "ORG RATING D &REMITUS COUNSELING OF PATIENT D
%XOGENOUS PATHWAY n F &UNCTIONAL REENTRY ABNORMAL IMPULSE CONDUCTION DIAGNOSIS AND CLINICAL MANIFESTATIONS n

%XONS D DIASTOLIC DYSFUNCTION n T
%XPLODING HEAD SYNDROME D &UNDUSCOPIC EXAMINATION TECHNIQUE ETIOLOGY OF n
%XPRESSIVE HOSTILITY IN CORONARY HEART DISEASE &USION BEAT D EVALUATION OF CAUSE OF T
%XTRACELLULAR FLUID HYPOTHESIZED RISK FACTORS OF T
BALANCE n G INHIBITORS OF 2!!3 n
DISTRIBUTION FOR n PATHOGENESIS OF n
%XTRACELLULAR FLUID OLUME %#6 n 'ADOLINIUM CHELATES PHYSIOLOGY OF n
CAUSES OF T 'LOBULINS PRELOAD AND AFTERLOAD REDUCING AGENTS FOR T
DEFICIT n T 'AP JUNCTION PROGNOSIS
EXCESS T 'ASTROEPIPLOIC GRAFT '%! WITH REDUCED AND PRESERVED EJECTION FRACTION
AND OSMOLALITY IMBALANCES 'ATED BLOOD POOL RADIONUCLIDE T
%XTRAVASCULAR LUNG WATER %6,7 '%! GRAFT 3EE 'ASTROEPIPLOIC GRAFT '%! SELF CARE EXPECTATIONS IN n
%XTREME AXIS 'ENES SEQUENCE OF EVENTS IN F

DEFINITION SURGICAL TECHNIQUES FOR
DEFINITION OF D
F TESTING OF SYNDROME OF
SYSTOLIC DYSFUNCTION
&AGERSTORM 4OLERANCE 1UESTIONNAIRE &41 VARIATION IN n (EART-ATE )) DEVICE F

&AGERSTROM TOLERANCE TEST F 'ENETIC DISEASE (EART RATE

F
F
&ASCICULAR BLOCK F D BIOCHEMICAL BASIS OF n AND CARDIAC OUTPUT
&AGERSTROM 4EST FOR .ICOTINE $EPENDENCE "RUGADA SYNDROME IN CONTROL OF n
&4.$ 'ENOME D DRUGS USED FOR Tn T
T
T
&ALSE NEGATIVE TEST RESULT D 'ENOTYPE D ON %#'
&ALSE POSITIVE TEST RESULT D 'LOMERULAR FILTRATION RATE '&2 AND RHYTHM
&AMILIAL HYPERCHOLESTEROLEMIA &( 'LUCAGON LIKE PEPTIDE ',0 (EART RATE FAILURE
&EAR 3EE !NXIETY 'LUCOSE BRAIN INJURY
&EMORAL ARTERY CONTROL CAFFEINE
&ENESTRATED VASCULAR ENDOTHELIUM F ESTIMATED AVERAGE OF T DEPRESSION

&ENN EFFECT INSULIN REPLACEMENT THERAPY (UNTINGTON
T
T
&IBRINOGEN T n LIFESTYLE MANAGEMENT n 0ARKINSON DISEASES
&IBRINOLYTIC AGENTS MEDICATION FOR TYPE $IABETES n (EART RATE VARIABILITY (26
CAUTIONS FOR n ESTIMATED AVERAGE T IN ANGINA
COMBINATION THERAPY OF 'LUCOSIDASE INHIBITORS n ARRHYTHMIA AND n
COMPARISON OF T 'LYCATED HEMOGLOBIN '(B 3EE ALSO BODY POSITION
COMPLICATIONS FOR 'LYCATED (EMOGLOBIN (B! # IN CARDIAC SURGERY n
CONTRAINDICATIONS FOR n 'LYCATED (EMOGLOBIN (B! # T FACTORS INFLUENCIN
&IBRINOLYTICS 'LYCEMIC CONTROL OF AGE
CONTRAINDICATIONS AND CAUTIONS FOR USE OF T 'UILLAIN "ARRE SYNDROME T BODY POSITION
PREHOSPITAL BRAIN INJURY
THERAPY OF n H #/0$ n
&IBRINOLYSIS DEPRESSION
&IBRINOLYTIC 4HERAPY 3EE 2EPERFUSION STRATEGY (AWTHORN IN BIOLOGICALLY CASED TREATMENT DIABETES
PHARMACOLOGICAL (EART GENERAL HEALTH n
F

F

&IBROUS SKELETON n F ANATOMY OF n F F GENETICS

&ILL TO EMPTY MODE CONGENITAL DEFECTS PAIN AS
&IRST DEGREE !6 BLOCK NONCORONARY DEVICE FOR n SEX AND SEX HORMONES
T
T
&IXED RATE PACING DRUGS USED TO CONTROL RHYTHM Tn T SLEEP AND WAKE
&+ FUNCTIONAL THERAPEUTIC CLASSIFICATION FREQUENCY DOMAIN ANALYSIS
&LAXSEED n HEALTHY DIETARY PLANS OF T GENERAL CONSIDERATION MEASUREMENT n

&LOW LIMITED DIFFUSION n LEFT PART n F T

&LUID BALANCE MERIDIAN FL WCHART OF F IN HEART FAILURE

DEFINED MURMURS n F IN HEART TRANSPLANTATION n
F
F

EXTRACELLULAR VOLUME OF n RIGHT PART n F T IN HYPERTENSION (4.

OSMOLALITY AND SURFACE OF F INTERVENTION IMPACT
PROCESSES INVOLVED n VALVULAR DISEASE MEASURES OF n T
&LUID IMBALANCE VIEWS OF n MECHANISMS OF
EXTRACELLULAR VOLUME T (EART DISEASE IN -) n
HYPERNATREMIA n T ATHEROSCLEROSIS MYOCARDIAL INFARCTION n
IN HYPONATREMIA T CARDIOVASCULAR STRATEGIES TO PROMOTE T
MIXED GENETIC CHANGES RELEVANT T